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• The salivary glands are important exocrine and endo- 
crine organs, whose role in oral health is well recognized. 
Only within the last 15 years has it become apparent that 
these glands also contribute to maintenance of systemic health. 
Salivary gland polypeptides promote health and well-being 
by aiding in wound healing, rnucosal protection, tissue and 
organ regeneration, and immunomodulation. It is proposed 
that salivary gland factors form an integral part of the body's 
homeostatic processes. In the their absence, a condition pro- 
moted by many diseases or by artificially removing the glands 
(sialadenectomy), oral and systemic health is jeopardized. 
When the salivary glands do not secrete their hormones prop- 
erly the organism is no longer able to normally regulate sev- 
eral functions since important homeostatic mechanisms be- 
come dysfunctional. This breakdown in homeostatic mecha- 
nisms results in the establishment of an alternative state, that 
of allostasis, which is generally associated with illness or sus- 
ceptibility to illness. It is proposed that the dysfunctional sali- 
vary glands facilitate the development of the pathologies as- 
sociated with various disorders, such as diabetes mellitus and 
enhanced sensitivity to endotoxin. 
INTRODUCTION 
• Some 20 years ago the immune system was generally 
considered to operate independently and autonomously in pro- 
tecting the body from unwelcomed invaders and injury. In the 
mid-1970's, the application of immunological tools to inves- 
tigations of neural and endocrine problems (1) led to a revo- 
lutionary concept: the immune system is a special adaptive 
mechanism that is intimately integrated with other neuroen- 
docrine homeostatic processes. This new immunological per- 
spective revealed an unexpected complexity in the interactions 
between behavioral, neural, endocrine and immune processes 
(2). It is now acknowledged that the body's defence system, 
an integral part of homeostatic processes, involves an intri- 
cate system of neural, endocrine, paracrine and autocrine com- 
munication. 
With the advent of the neuroendocrineimmunological para- 
digm it has become apparent that the traditional roles assigned 
of certain glands and organs need to be reexamined. One such 
glandular system that has acquired importance, in view of the 
fine control exerted by neuroimmunological integrator mecha- 
nisms, is the salivary glands. Once regarded as an accessory 
digestive organ, the salivary glands are in actual fact a rich 
source of biologically active peptides that play an important 
role in the maintenance of healthy tissues and participate in 
growth and differentiation, inflammation and wound healing 
(3-5). Salivary gland dysfunction probably contributes to the 
development and maintenance of some pathological conditions. 
SALIVARY GLANDS IN HEALTH AMD DISEASE 
•         Salivary glands and oral health      
The approximately 500 ml of saliva produced each day is vital 
for the maintenance of health and function of the periodontium. 
Specific components in saliva provide protection of hard and 
soft tissue, facilitate speech, mastication and deglutition, and 
  
  
the amylases and ribonucleases found in saliva contribute to 
digestion. A substantial portion of the oral host defence mecha- 
nisms (antimicrobial - bacterial, fungal and viral) is mediated 
by families of salivary proteins: the proline-rich proteins (PRP), 
staterins, cystatins and histatins, which account for more than 
70 % of total salivary proteins (6). Mucosal and gingival in- 
tegrity is maintained by the lubricating action of salivary gly- 
coproteins and mucins (6,7) and several poorly characterized 
proteins that down-regulate neutrophil function (8). Dysfunc- 
tional saliva flow, caused by systemic diseases or of iatrogenic 
(caused by drugs or cancer therapies) origin, generally results 
in poor oral hygiene (7). Furthermore, as our understanding 
of salivary gland function increases it is becoming more ap- 
parent that these glands have a profound impact on systemic 
health as well. 
Q         Other functions of salivary gland secretions 
Barka (3) in 1980 proposed that salivary gland secretions con- 
tribute to homeostasis. This review summarized the occurrence, 
chemical properties, localization, hormonal control, secretion 
and possible physiological roles of some 25 biologically active 
peptides in the submandibular glands. Since then other en- 
zymes, growth factors, immunomodulatory factors, and pep- 
tides of unknown function have been found in salivary glands. 
Given the structural and functional diversity, as well as the 
phylogenetic conservation, of these polypeptides the funda- 
mental question remains: "Why are they present in the sali- 
vary glands?". The exocrine secretion of these factors is very 
important in oral health. By recognizing that salivary gland 
exocrine secretions are swallowed and enter into the blood 
stream where they act as endocrine hormones, the fundamen- 
tal importance of these glands in the regulation of systemic 
homeostasis becomes more evident. 
•         Wound healing  
Although epidermal growth factor (EGF) was isolated from 
the submandibular glands of mice based on developmental 
effects on eyelid opening and eruption of incisors (9), it was 
not recognized until much later that factors in saliva contrib- 
ute to the healing of wounds to the skin (10). Interestingly, 
wound healing occurs more rapidly if communal grooming 
and licking occurred than if the mice are housed individually. 
Some of the salivary gland factors responsible for wound con- 
traction are EGF (11,12), nerve growth factor (NGF) (13) and 
transforming growth factor-B (TGF-B) (12). These factors also 
contribute to the healing of intestinal lesions (14). 
•         Mucosal protection 
The salivary glands and their growth factors, in particular EGF 
and NGF, exert significant protective effects on the gastric 
(15) and oesophageal (16) mucosa. This latter study is of par- 
ticular significance since it demonstrates that the healing and 
protective effect of salivary gland EGF applies also to humans 
and is not exclusively a phenomenon restricted to rodents. An 
important distinction, however, is that salivary gland EGF is 
found predominately in the submandibular glands of rodents, 
but in the parotid gland of humans (17). The mucosal protec- 
tive effects of salivary gland growth factors are attributable to 
inhibition of acid secretion and induction of tissue repair 
mechanisms, and possibly stimulation of mucosal blood flow 
(18). Nonetheless, a dissociation between mucosal protection 
and microvascular perfusion has been noted (19). 
•         Tissue and organ regeneration 
For a large part the exocrine secretion of growth factors into 
saliva accounts for the wound healing and mucosal protection 
and repair, although following salivary duct ligation wound 
contraction occurs more rapidly than in sialadenectomized 
animals (10). This observation, which suggests an endocrine 
component to the healing effects of salivary gland factors, helps 
explain the role of salivary factors on a variety of proliferative 
and differentiation events. Submandibular gland EGF promotes 
mammary tumor formation in mice (20). Marked effects of 
the salivary glands on the reproductive tract have also been 
noted. Sialadenectomy, which reduces circulating levels of EGF 
(21), results in lower uterine weights, delayed implantation 
and an increased abortion rate (22), although ovary weights 
are not affected. The same operation in male mice markedly 
inhibits the meiotic phase of spermatogenesis since the num- 
ber of mature sperm in the epididymis and spermatids in the 
testis are reduced by approximately 50 %, whereas the num- 
ber of spermatids in the testis increases (21). Humoral factors 
released from the salivary gland are also required for liver 
regeneration (23), and ligation of the venous drainage of the 
major salivary glands inhibits the increase in DNA synthesis 
in the remaining liver tissue following partial hepatectomy 
(24). This dependence of liver regeneration on the salivary 
glands may be due to the presence of hepatocyte growth factor 
in the submandibular glands (25). Other tissue protective and 
regenerative effects of salivary gland factors will undoubtedly 
be discovered. 
•         Immunomodulation 
The suggestion that the submandibular glands contain factors 
that can suppress immune and inflammatory reactions in ro- 
dents were first mentioned in the 1970's (26-29). More re- 
cently, some factors that either stimulate or inhibit lympho- 
cyte proliferation (30,31), and development of normal bone 
marrow cell precursors (32) have been isolated from subman- 
dibular glands. Some of the better studied growth factors found 
in the submandibular glands, such as NGF, EGF and TGF-6,   
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possess immunomodulatory activities that could modify both 
periodontal (33), as well as systemic immune responses 
(3,5,34). 
Nonetheless, the identification of immune modifying activi- 
ties and factors within a gland does not necessarily extrapo- 
late to the situation that the gland itself plays a role in modu- 
lating the immune response. However, experimental data sup- 
port this hypothesis. Sialadenectomy results in a suppressed 
immune response to sheep red blood cells (35) and an inhibi- 
tion of delayed hypersensitivity (36), although this latter ob- 
servation is contradicted by an earlier study (29). When patho- 
physiological responses to immunological insults are exam- 
ined it is apparent that the presence of the submandibular 
glands increases immediate hypersensitivity reactions in the 
lungs (37), but prevents the severity of the circulatory shock 
induced by endotoxin (38). 
Thus, just as removal of the submandibular glands can affect 
reproduction, hepatic regeneration, the development of ulcers 
and wound healing, sialadenectomy has a profound influence 
on the ability of the immune system to respond to antigenic 
and toxic stimuli. The salivary glands thus appear to be in- 
volved in maintaining normal body function. This concept, 
which has been discussed previously (4,5,39), proposes that a 
neuroendocrinoimmunological circuit that is comprised of the 
hypothalamus, the cervical sympathetic trunk and the subman- 
dibular glands. 
However, the question still remains, given the numerous and 
large variety of growth factors found in the salivary glands: 
"What role do they actually play in homeostasis?" 
HOMEOSTASIS, ALLOSTASIS and RHEOSTASIS 
• Homeostasis, which implies a constancy of the "milieu 
interieur" has contributed enormously to our understanding 
of biological processes. As developed by Cannon (40), homeo- 
stasis embraces the idea of a stable internal environment, but 
also emphasizes the importance of dynamic equilibria and 
variability. However, contemporary definitions of homeosta- 
sis highlight the "maintenance of static, or constant, condi- 
tions of the internal environment" (41). Consequently, some 
authors have mistakenly argued that homeostasis cannot ac- 
count for the continual redefining of steady state that occurs 
in face of circadian, mensural and circumannual variations in 
physiological parameters, as well as those changes imposed 
by exercise, stress and disease (42,43). Sterling and Eyer (42) 
have proposed that the continual setting of new operating 
ranges of the body's vital functions is achieved by the process 
of allostasis. Accepting this definition of allostasis essentially 
requires that homeostasis be discarded as an operative and 
useful process. Rather than having the term homeostasis be- 
come an archaism an alternative term, rheostasis proposed by 
Mrosovsky (44), maintains that homeostasis is valuable and 
physiologically relevant. Rheostasis describes "the regulation 
around shifting set-points" (44), that occur within a range of 
values compatible with homeostasis. Nevertheless, an expanded 
version of the concept of allostasis is useful, when put in a 
context somewhat different from that originally proposed (42). 
This new formulation requires incorporation of the idea of 
allostatic load (43). 
•        Allostatic load 
The basic proposition of allostatic load is that the continual 
changes in physiological functions required for the repeated 
resetting of steady states and operating levels, can impose a 
strain which predisposes the organism to disease. An example 
of allostatic load is combined elevation of cortisol and insulin 
secretion, which may accelerate the development of athero- 
sclerosis (43,45). The problem with this definition of allostatic 
load is that it does not clearly distinguish between the pro- 
cesses (the physiological changes - elevated cortisol and insu- 
lin) and the result of these processes (atherosclerosis). 
•         Redefining allostasis 
Rather than discarding the concept of homeostasis under the 
pretence that constant changes in physiological variables pre- 
cludes it as a valid concept, homeostasis should be viewed as 
encompassing the many different set points that manage the 
normal cyclical variations in physiology. Rheostatic processes 
contribute to the development of the new steady states within 
the homeostatic domain irregardless of their duration and sta- 
bility (Fig. 1). Allostatic load then describes the processes which 
contribute to the movement of set points and steady states out- 
side the domain that defines normal homeostasis, such that 
other regulatory mechanisms become active with the break- 
down in homeostatic processes. As a consequence of allostatic 
load an organism may shift from homeostatic to allostatic con- 
trol. Some examples of allostatic load are: the overuse of a 
homeostatic process (excess insulin secretion), the disappear- 
ance of a normal physiological process (the destruction of the 
6-cell with associated decrease in insulin secretion) and an 
alteration in receptor-effector signal transduction (insulin re- 
ceptor desensitization). 
These new allostatic states are abnormal and generally patho- 
logical. Within this schema increased stresses (e.g. increased 
metabolic demands, infection, social and work obligations, etc) 
contribute to allostatic load which could favour the develop- 
ment of allostatic states, but only after offsetting, overriding 
and displacing the normal homeostatic processes, which in- 








Figure 1. Homeostasis comprises the neural, endocrine and immunological mechanisms that maintain a physiological and 
biochemical parameter within a well defined range. The star in the middle represents an average set point or steady state. 
Under the influence of various stressors (allostatic load) the body may no longer be able to conserve a given parameter 
within the range manageable by homeostatic mechanisms. A pathology develops and an alternate state, that ofallostasis, 
develops. It may be difficult, but not impossible, to return to the homeostatic state. 
  
•        Allostasis and diabetes mellitus 
The regulation of blood sugar levels is used to illustrate how 
the concepts of homeostasis, allostasis and allostatic load con- 
tribute to our understanding of the development of disease 
(Fig.2). Blood sugar levels are kept within a relatively narrow 
range, although fluctuations occur according to the time of 
day, age, exercise, and consumption of foods and drugs (46). 
These changes reflect the workings of normal homeostatic 
processes (the interactions of neuronal and endocrine systems) 
that modify set points in response to demands placed on the 
body. If, however, a stress, such as an inappropriate diet is 
imposed on the body, normal homeostatic mechanisms (e.g. 
glucocorticoids and insulin) may not be able to adequately 
control blood sugar levels. Allostatic load, such as excess pro- 
duction and release of insulin, reflects an attempt to correct 
the sugar imbalance. Even with these allostatic processes 
hyperglycaemia may persisit for extended periods of time, but 
if uncorrected a dysfunction in homeostasis may occur. This 
situation is not necessarily permanent provided that the cor- 
rective measures are taken to correct the imbalance (e.g. im- 
proved diet). However, with certain individuals this undue 
stress, especially if it is not corrected and if there exists con- 
currently a genetic predisposition to diabetes or obesity (an- 
other form of allostatic load), the onset of diabetes inevitably 
ensues. The prediabetic individual can no longer maintain 
blood sugars adequately in the normal range by homeostatic 
mechanisms, and becomes an overt diabetic when blood sugar 
is controlled by other (i.e. allostatic) processes. Some of the 
allostatic processes used to control the hyperglycaemia are the 
deposition of fat, polyuria and polydipsia. Allostatic processes 
contributing to the pathology include insulin resistance and 
the shunting of glucose metabolism to the polyol pathway. 
The polyol metabolic pathway reduces the availability of 
phosphotidyl inositol required for normal functioning of the 
Na%K
+
-ATPase, and is believed to contribute to diabetic 
neuropathy (47). 
The development of diabetes represents a shift from a ho- 
meostatic to allostatic state. The shift back to normal ho- 
meostatic control mechanisms is difficult, if not virtually im- 
possible, and various long-term therapies must be initiated in 
order to control the pathology. 
THE SALIVARY GLANDS: ROLE IN HOMEOSTATIC 
AND ALLOSTATIC PROCESSES 
•         Homeostatic regulation by salivary secretions 
Like most physiological variables salivary secretion is not con-   
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Figure 2. Homeostatic and allostatic control is exemplified by considering control of blood glucose levels. Normal blood 
glucose takes on a range of values depending upon individual differences, age, diet, circadian rhythms and exercise, as is 
shown by the circle labelled euglycaemia. Under certain conditions the variations in blood sugar levels move outside this 
normal range, as occurs with the development of modest and acute hyperglycaemia. Although modest and acute hyper- 
glycaernia is not normal, homeostatic mechanisms can still bring blood glucose back into the normal ranges (arrow 1). 
However, if under conditions of allostatic load (e.g. persistent hyperglycaemia and genetic predispositions) the individual 
becomes diabetic (arrow 2), and he/she then has moved into another state: one of allostasis. Diet management, insulin therapy 
and other drug treatments can correct, in part, the chronic and severe hyperglycaemia (arrow 3), but rarely is the individual 
able to achieve continued and permanent euglycaemia. The underlying pathology frequently prevents the return to homeo- 
static control (arrow 4). 
  
slant, but it is regulated by homeostatic processes to meet the 
changing demands imposed by environmental and sensory 
inputs. The sense of smell and the ingestion of food (9), as 
well as light (48) are key stimuli in eliciting salivary secre- 
tions. The increase of salivary secretions are needed during 
feeding to facilitate chewing and swallowing (7,49), and prob- 
ably contributes to the maintenance of mucosal integrity dur- 
ing eating, as evidenced by increases in salivary EGF follow- 
ing mechanical stimulation of the oesophagus (50). Even un- 
der non-dietary demands salivary flow changes: keeping the 
mouth moist is essential for speaking. The salivary secretions 
of NGF and EGF also exhibit diurnal variation (51). Condi- 
tions of psychological stress, such as aggressive behavior, lead 
to an increase in circulating levels of NGF which derives from 
the salivary glands (52,53). The reason for this increase in 
circulating NGF is not known, but may be related to the adre- 
nal gland hypertrophy that occurs with repeated fighting (52). 
Thus, salivary secretion is a dynamic process that is continu- 
ously modified to establish different and changing set points 
under the influence of specific demands. 
•         Allostatic regulation of salivary secretion 
Salivary gland dysfunction, and concurrent xerostomia, is as- 
sociated with a variety of connective tissue diseases identified 
with Sjo'gren's syndrome, such as rheumatoid arthritis, sys- 
temic lupus erythematosus, progressive systemic sclerosis, 
primary biliary cirrhosis and atrophic gastritis. Other condi- 
tions that manifest xerostomia are diabetes mellitus, cystic fi- 
brosis, sarcoidosis, neurological disorders, and the graft-versus- 
host disease associated with bone marrow transplantation. For 
the majority of these disorders the xerostomia may be caused by 
the disease, although in certain cases a dysfunctional salivary 
gland could contribute to exacerbation of the disease. 
•         The salivary glands and diabetes mellitus 
The allostatic model of physiological regulation proposed above 
suggests that if salivary secretion is dysfunctional then other 
physiological processes, which are inherently inappropriate 
for maintenance of normal function will become operative.   
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These compensatory changes may help maintain a functional 
organism, but in the long run they cannot respond appropri- 
ately to the demands placed on the organism. 
A case in point is the alteration of salivary gland function in 
diabetes mellitus. Some of the pathology associated with dia- 
betes may result from a deficiency in salivary gland secretion 
of EGF. Xerostomia and poor oral hygiene (54), reflux esopha- 
gitis and poor wound healing (55) are common in diabetics. 
An insulin correctable deficiency in the production of EGF by 
the submandibular glands was reported in diabetic mice (56, 
57). The glandular dysfunction is associated with a chronic 
lymphocytic infiltration, glandular disorganization and de- 
struction of the ductal cells, the source of salivary gland EGF 
(56). Although diabetes mellitus is identified with salivary 
gland dysfunction, their removal from diabetic rats results in 
a normalization of blood glucose levels (58). This antigly- 
caemia effect of sialadenectomy, which does not occur in non- 
diabetic rats, was attributed to the presence and release of 
extrapancreatic glucagon from the submandibular glands of 
the diabetic rats, and illustrates allostatic compensation by the 
salivary glands facing non-operative or dysfunctional homeo- 
static mechanisms. 
•        Modulation of shock responses 
The importance of the submandibular glands in regulating 
homeostasis is further illustrated by the ability of these glands 
to determine the severity of shock responses to an endotoxic 
stimulus (38). Removal of the submandibular glands results 
in a more severe hypotensive response to intravenously ad- 
ministered endotoxin. Although the mechanisms respon- 
sible for this enhanced sensitivity to endotoxin have not been 
clearly established vascular reactivity to adrenergic neurotrans- 
mitters may be partly responsible (unpublished observations), 
and/or the ability of the neutrophils and macrophages to deal 
with the toxin may be modified (59,60). 
The sensitization to endotoxin by sialadenectomy suggests that 
factors released from the submandibular glands modulate vas- 
cular and immune cell reactivity to inflammatory stimuli. These 
factors, acting as endocrine hormones, probably control the 
homeostatic mechanisms responsible for dealing with and re- 
sponding to endotoxin and other inflammatory stimuli, such 
as antigen provocation of hypersensitivity reactions (37). Sup- 
port for the notion that the submandibular glands regulate 
immunoregulatory homeostatic mechanisms was obtained 
when it was found that the effect of the removal of these glands 
on the severity of endotoxin-induced hypotension exhibited 
diurnal and circumannual variation (61). Sialadenectomy, by 
eliminating the source of immunomodulatory factors, removes 
inhibitory constraints that may prevent an excessive and harm- 
nil reaction to circulating endotoxin. Upon removal of the sub- 
mandibular glands one of the mechanisms responsible for 
homeostatic regulation of the responses to endotoxin is no 
longer available. Sialadenectomy is analogous to imposing an 
allostatic load, which is severe enough to move the animal 
into another state, an allostatic one, with its enhanced reactiv- 
ity to endotoxin (Fig.3). 
CONCLUSIONS 
• By incorporating the concept of allostasis, which im- 
plies "another state" that is controlled differently from the 
homeostatic state, an understanding of the role of salivary 
glands in the regulation of body function is achievable. Sali- 
vary glands are consequently considered important participants 
in the regulation and maintenance of homeostasis. Dysfunc- 
tional glands, with a modified profile of exocrine and endo- 
crine secretions, lead to marked perturbation of homeostasis. 
If these perturbations, defined as allostatic load, are of suffi- 
cient magnitude they lead to fundamental change in how the 
body responds to metabolic and environmental challenges. This 
modified state is an allostatic one. Further studies are required 
to evaluate salivary gland function in various diseases in or- 
der to determine the contribution that modified salivary gland 
secretions make to the development of specific pathologies. 
The profound impact of connective tissue diseases on the sali- 
vary glands suggests that this area of research should be quite 
productive. 
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